Global Herpes Market, By Type (Herpes Simplex Virus Type 1, Herpes Simplex Virus Type 2, Others), Treatment (Medications, Therapy, Others), Drugs (Acyclovir, Famciclovir, Valacyclovir, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027.
Market Analysis and Insights: Global Herpes Market
Herpes market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of sexually transmitted diseases disorders worldwide and emerging markets are the factors responsible for the growth of this market.
However, rising prevalence of STDs such as HIV, Hepatitis & others, rising awareness programmes worldwide through campaigns & media and Vulnerable aging population as they highly prone to herpes zoster viral infection. But, lack of patient awareness, self-medication and weak pipeline for herpes zoster may hamper the global herpes market.
Herpes is the sexually transmitted disease caused by herpes simplex virus. HSV-1 can transmitted by the oral-to-oral contact to cause oral herpes which includes cold sores while, HSV-2 can be transmitted by the sexually which causes genital herpes. Both the type of infection are asymptomatic but may causes mild to severe symptoms and causes painful blisters and ulcer. I;N 2017 WHO estimated that 3.7 billion people under age 50 (67%) have HSV-1 infection globally and 417 million people aged 15-49 (11%) worldwide have HSV-2 infection.
Herpes market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Herpes Market Scope and Market Size
The herpes market is segmented on the basis of type, treatment, drugs, route of administration, end-users and distribution channel.
- On the basis of type, the herpes market is segmented into herpes simplex virus type 1, herpes simplex virus type 2 and others.
- On the basis of treatment, the herpes market is segmented into medications, therapy and others. Medication further divided into antiviral, corticosteroids, pain relievers and others
- On the basis of drugs, the herpes market is segmented into acyclovir, famciclovir, valacyclovir and others
- Route of administration segment of herpes market is segmented into oral, parenteral and others
- On the basis of end-users, the herpes market is segmented into hospitals, specialty clinics and others
- On the basis of distribution channel, herpes market has also been segmented into hospital pharmacy, retail pharmacy others
Herpes Market Country Level Analysis
Global herpes is analysed and market size information is provided by country, type, treatment, drugs, route of administration, end-users and distribution channel as referenced above.
The countries covered in the herpes market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographically basis North America dominates the market share due to increased investment by pharmaceutical industries for the advancement in the treatment and favourable reimbursement scenario. Europe is expected to holds second largest market for herpes due to supportive government policies and raising public awareness about Herpes treatments. Asia-Pacific is expected to account for the largest market share over coming years for the herpes market due to rapidly improving health care infrastructure in the region
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global herpes market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Herpes Market Share Analysis
Global herpes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Herpes market.
The major players covered in the herpes market are Bausch Health Companies Inc., Mylan N.V., GlaxoSmithKline Plc., Aurobindo Pharma Ltd., Novartis AG, Hikma Pharmaceutical PLC, Teva Pharmaceutical Industries Ltd., Cipla Inc., Wockhardt, Sun Pharmaceutical Industries Ltd. and among.
Customization Available: Global Herpes Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in crAnxietypresentations from the data sets available in the report.